Clinical effectiveness, safety and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomised, phase III trial (original) (raw)

Additional Information:

We acknowledge funding from the Chief Scientist’s Office, Scottish Government, and from Cancer Research UK.

Glasgow Author(s) Enlighten ID:

Gunson, Dr Rory and Paterson, Miss Lucy and Scott, Dr Janet and Blyth, Professor Kevin and Jones, Professor Robert and Da Silva Filipe, Dr Ana and McCartney, Miss Elaine and Thomson, Professor Emma and Divers, Miss Laura and Cunningham, Miss Laura and Berry, Professor Colin and Carmichael, Dr Samantha and Holland, Dr Poppy and Shaw, Ms Ann and Tong, Dr Lily and Kelly, Mrs Caroline and MacGregor, Professor Gordon and Illingworth, Dr Chris and McInnes, Professor Iain and Vattipally, Dr Sreenu

Creator Roles:

Illingworth, C.Formal analysis, Investigation, Writing – review and editing
MacGregor, G.Supervision
Cunningham, L.Project administration
Divers, L.Project administration
McCartney, E.Formal analysis, Validation, Writing – review and editing
Paterson, L.Formal analysis, Validation, Writing – review and editing
Kelly, C.Formal analysis, Validation, Writing – review and editing
Shaw, A.Project administration
Holland, P.Investigation
Carmichael, S.Resources
Scott, J.Conceptualization, Funding acquisition, Methodology
Berry, C.Supervision, Writing – review and editing
Vattipally, S.Investigation, Writing – review and editing
Da Silva Filipe, A.Investigation, Writing – review and editing
Tong, L.Investigation, Writing – review and editing
Gunson, R.Investigation, Writing – review and editing
McInnes, I.Supervision, Writing – review and editing
Jones, R.Supervision, Writing – review and editing
Thomson, E.Conceptualization, Investigation, Supervision, Writing – review and editing
Blyth, K.Conceptualization, Funding acquisition, Project administration, Supervision, Writing – original draft, Writing – review and editing

Authors:

Tate, M., Illingworth, C. J.R., MacGregor, G., Cunningham, L., Divers, L., McCartney, E., Paterson, L., Kelly, C., Shaw, A., Perkins, J. S., Silva, V., Holland, P., Dalton, C., Carmichael, S., Douglas, E., Surtees, P., Scott, J. T., Berry, C., Vattipally, S., Da Silva Filipe, A., Tong, L., Gunson, R., GETAFIX trial co-investigators, , McInnes, I. B., Jones, R., Thomson, E., and Blyth, K.

Publisher:

American Society for Microbiology

First Published:

First published in Antimicrobial Agents and Chemotherapy 69(8): e0005425

Publisher Policy:

Reproduced under a Creative Commons License